{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "20", "@timestamp": "2023-05-20T23:31:52.000052-04:00", "@year": "2023", "@month": "05"}, "ait:date-sort": {"@day": "15", "@year": "2017", "@month": "01"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Sanofi Pasteur", "xocs:funding-agency": "Sanofi Pasteur", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014588", "xocs:funding-agency-country": "http://sws.geonames.org/3017382/"}, {"xocs:funding-agency-matched-string": "Sanofi Pasteur", "xocs:funding-agency": "Sanofi Pasteur", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014588", "xocs:funding-agency-country": "http://sws.geonames.org/3017382/"}], "xocs:funding-addon-generated-timestamp": "2021-03-21T01:01:33.892Z", "xocs:funding-text": [{"$": "Financial support. Funding for this study was provided by Sanofi Pasteur. The sponsor participated in the study design and managed all operational aspects of the study, including writing of this report."}, {"$": "Potential conflicts of interest. E. F., C. M., and A. B. are Sanofi Pasteur employees. M. B. was a Sanofi Pasteur employee at the time of the study and testing determination. The institutions of S. Y., K. C., U. T., and C. P. have received research grants from Sanofi Pasteur. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."}], "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "France", "address-part": "1541 Ave Marcel M\u00e9rieux", "postal-code": "69280", "@afid": "60065719", "@country": "fra", "city": "Marcy l'Etoile", "organization": [{"$": "Clinical Development"}, {"$": "Sanofi Pasteur"}], "affiliation-id": {"@afid": "60065719", "@dptid": "117095014"}, "@dptid": "117095014"}, "author": [{"ce:given-name": "Emmanuel", "preferred-name": {"ce:given-name": "Emmanuel", "ce:initials": "E.", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, "@seq": "1", "ce:initials": "E.", "@_fa": "true", "@type": "auth", "ce:surname": "Feroldi", "@auid": "23388879400", "ce:indexed-name": "Feroldi E."}, {"ce:given-name": "C\u00e9line", "preferred-name": {"ce:given-name": "C\u00e9line", "ce:initials": "C.", "ce:surname": "Monfredo", "ce:indexed-name": "Monfredo C."}, "@seq": "7", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Monfredo", "@auid": "57191196788", "ce:indexed-name": "Monfredo C."}]}, {"affiliation": {"country": "United States", "@afid": "60065719", "@country": "usa", "organization": [{"$": "Global Clinical Immunology"}, {"$": "Sanofi Pasteur"}, {"$": "Swiftwater"}], "affiliation-id": {"@afid": "60065719", "@dptid": "122710925"}, "state": "PA", "@dptid": "122710925"}, "author": [{"ce:given-name": "Mark", "preferred-name": {"ce:given-name": "Mark", "ce:initials": "M.", "ce:surname": "Boaz", "ce:indexed-name": "Boaz M."}, "@seq": "2", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:surname": "Boaz", "@auid": "57209785027", "ce:indexed-name": "Boaz M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60012718", "@country": "tha", "organization": [{"$": "Center for Vaccine Development"}, {"$": "Institute of Molecular Biosciences"}, {"$": "Mahidol University"}, {"$": "Translational Research Unit"}], "affiliation-id": {"@afid": "60012718", "@dptid": "121383852"}, "@dptid": "121383852"}, "author": [{"ce:given-name": "Sutee", "preferred-name": {"ce:given-name": "Sutee", "ce:initials": "S.", "ce:surname": "Yoksan", "ce:indexed-name": "Yoksan S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Yoksan", "@auid": "7003989454", "ce:indexed-name": "Yoksan S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60199575", "@country": "tha", "organization": [{"$": "Division of Infectious Diseases"}, {"$": "Siriraj Hospital"}, {"$": "Bangkok"}], "affiliation-id": {"@afid": "60199575", "@dptid": "125771095"}, "@dptid": "125771095"}, "author": [{"ce:given-name": "Kulkanya", "preferred-name": {"ce:given-name": "Kulkanya", "ce:initials": "K.", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, "@seq": "4", "ce:initials": "K.", "@date-locked": "2019-11-21T23:09:57.754", "@_fa": "true", "@type": "auth", "ce:surname": "Chokephaibulkit", "@auid": "7003974471", "ce:indexed-name": "Chokephaibulkit K."}]}, {"affiliation": {"country": "Thailand", "@afid": "60022183", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pediatrics"}, {"$": "Chulalongkorn Hospital"}], "affiliation-id": {"@afid": "60022183", "@dptid": "104136197"}, "@dptid": "104136197"}, "author": [{"ce:given-name": "Usa", "preferred-name": {"ce:given-name": "Usa", "ce:initials": "U.", "ce:surname": "Thisyakorn", "ce:indexed-name": "Thisyakorn U."}, "@seq": "5", "ce:initials": "U.", "@_fa": "true", "@type": "auth", "ce:surname": "Thisyakorn", "@auid": "7005343826", "ce:indexed-name": "Thisyakorn U."}, {"ce:given-name": "Chitsanu", "preferred-name": {"ce:given-name": "Chitsanu", "ce:initials": "C.", "ce:surname": "Pancharoen", "ce:indexed-name": "Pancharoen C."}, "@seq": "6", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Pancharoen", "@auid": "7006397913", "ce:indexed-name": "Pancharoen C."}]}, {"affiliation": {"country": "Singapore", "@afid": "118763766", "@country": "sgp", "city": "Sanofi Pasteur", "organization": {"$": "Medical Affairs and Clinical RandD"}, "affiliation-id": {"@afid": "118763766", "@dptid": "122732446"}, "@dptid": "122732446"}, "author": [{"ce:given-name": "Alain", "preferred-name": {"ce:given-name": "Alain", "ce:initials": "A.", "ce:surname": "Bouckenooghe", "ce:indexed-name": "Bouckenooghe A."}, "@seq": "8", "ce:initials": "A.", "@date-locked": "2021-02-23T02:49:31.847", "@_fa": "true", "@type": "auth", "ce:surname": "Bouckenooghe", "@auid": "18233281300", "ce:indexed-name": "Bouckenooghe A."}]}, {"affiliation": {"country": "United States", "@afid": "60090013", "@country": "usa", "city": "New York", "organization": {"$": "Present Affiliation: International AIDS Vaccine Initiative"}, "affiliation-id": {"@afid": "60090013"}, "state": "NY"}, "author": [{"ce:given-name": "Emmanuel", "preferred-name": {"ce:given-name": "Emmanuel", "ce:initials": "E.", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, "@seq": "1", "ce:initials": "E.", "@_fa": "true", "@type": "auth", "ce:surname": "Feroldi", "@auid": "23388879400", "ce:indexed-name": "Feroldi E."}]}], "citation-title": "Persistence of wild-type Japanese encephalitis virus strains cross-neutralization 5 years after JE-CV immunization", "abstracts": "\u00a9 The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.Background. The live-Attenuated Japanese encephalitis (JE) vaccine (JE-CV; IMOJEV) induces a protective response in children. A shift in circulating JE virus strains suggests that a genotype shift phenomenon may occur throughout Southeast Asia. We assessed the neutralization of wild-Type (WT) JE virus isolates at distal time points after vaccination. Methods. We analyzed serum samples from a subset of 47 children who had received a JE-CV booster after an inactivated JE vaccine primary immunization. We measured antibody titers (50% plaque reduction neutralization test) using a panel of WT JE strains at baseline, then after the booster at 28 days and 6 months in all subjects present at the time points and in a subset at year 5. Three additional recent isolates were tested at year 5. Results. Of 47 subjects, 43 (91.5%) subjects had JE neutralizing antibody titers =10 (reciprocal serum dilution) against the homologous strain before JE-CV boost; all were seroprotected up to year 5 after the JE-CV boost. Baseline WT seroprotection ranged between 78.7% and 87.2%; all subjects were seroprotected against the 4 WT strains at 28 days and 6 months; year 5 seroprotection ranged between 95.7% and 97.9%. Similar rates of protection against 3 additional WT isolates were observed at year 5. Conclusions. The long-Term immune responses induced after a JE-CV booster dose in toddlers were able to neutralize WT viruses from various genotypes circulating in Southeast Asia and India. Clinical Trials Registration. NCT00621764.", "correspondence": {"affiliation": {"country": "France", "address-part": "1541 Ave Marcel M\u00e9rieux", "postal-code": "69280", "@country": "fra", "city": "Marcy l'Etoile", "organization": [{"$": "Clinical Development"}, {"$": "Sanofi Pasteur"}]}, "person": {"ce:given-name": "Emmanuel", "ce:initials": "E.", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Genotypes", "@xml:lang": "eng"}, {"$": "Japanese encephalitis vaccines", "@xml:lang": "eng"}, {"$": "Long-Term protection", "@xml:lang": "eng"}, {"$": "Wild-Type strains; cross-neutralization", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://jid.oxfordjournals.org/content/current", "@type": "email"}}, "translated-sourcetitle": {"$": "Journal of Infectious Diseases", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "215", "@issue": "2"}, "pagerange": {"@first": "221", "@last": "227"}}, "@type": "j", "sourcetitle": "Journal of Infectious Diseases", "publicationdate": {"month": "01", "year": "2017", "date-text": {"@xfab-added": "true", "$": "15 January 2017"}, "day": "15"}, "codencode": "JIDIA", "sourcetitle-abbrev": "J. Infect. Dis.", "@country": "gbr", "issn": [{"$": "15376613", "@type": "electronic"}, {"$": "00221899", "@type": "print"}], "publicationyear": {"@first": "2017"}, "publisher": {"publishername": "Oxford University Press"}, "@srcid": "22440"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "ASJC", "classification": "2700"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": {"@source": "nlm", "chemical": [{"chemical-name": "Antibodies, Neutralizing"}, {"chemical-name": "Antibodies, Viral"}, {"chemical-name": "Japanese Encephalitis Vaccines"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "external-source": "MEDLINE", "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "MOSYEA"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "28", "@timestamp": "BST 08:24:58", "@year": "2018", "@month": "09"}}, "itemidlist": {"itemid": [{"$": "624037440", "@idtype": "PUI"}, {"$": "616706572", "@idtype": "associatedPUI"}, {"$": "2018296875", "@idtype": "CABS"}, {"$": "912869859", "@idtype": "CAR-ID"}, {"$": "20180668930", "@idtype": "EMBASE"}, {"$": "27815383", "@idtype": "MEDL"}, {"$": "2018104979", "@idtype": "MOSYEA"}, {"$": "2018320223", "@idtype": "NURSNG"}, {"$": "20181708248", "@idtype": "REAXYSCAR"}, {"$": "20182890373", "@idtype": "SCOPUS"}, {"$": "85021858117", "@idtype": "SCP"}, {"$": "85021858117", "@idtype": "SGR"}, {"$": "616706572", "@idtype": "PUIsecondary"}], "ce:doi": "10.1093/infdis/jiw533"}}, "tail": {"bibliography": {"@refcount": "31", "reference": [{"ref-fulltext": "Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004; 10(12 suppl):S98-109.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Emerging flaviviruses: The spread and resurgence of Japanese encephalitis"}, "refd-itemidlist": {"itemid": {"$": "10944252079", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10", "@issue": "12"}, "pagerange": {"@first": "S98", "@last": "109"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Mackenzie", "ce:indexed-name": "Mackenzie J.S."}, {"@seq": "2", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Gubler", "ce:indexed-name": "Gubler D.J."}, {"@seq": "3", "ce:initials": "L.R.", "@_fa": "true", "ce:surname": "Petersen", "ce:indexed-name": "Petersen L.R."}]}, "ref-sourcetitle": "West Nile and Dengue Viruses. Nat Med"}}, {"ref-fulltext": "Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 2000; 18(suppl 2):1-25.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand"}, "refd-itemidlist": {"itemid": {"$": "0034724144", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2000", "@issue": "2-18"}, "pagerange": {"@first": "1", "@last": "25"}}, "ref-text": "13-15 October", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Tsai", "ce:indexed-name": "Tsai T.F."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: A systematic review. Bull World Health Organ 2011; 89:766-74, 74A-74E.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Estimated global incidence of Japanese encephalitis: A systematic review"}, "refd-itemidlist": {"itemid": {"$": "80053498530", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "89"}, "pagerange": {"@first": "766", "@last": "774"}}, "ref-text": "Fischer, 74A-74E", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.L.", "@_fa": "true", "ce:surname": "Campbell", "ce:indexed-name": "Campbell G.L."}, {"@seq": "2", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Hills", "ce:indexed-name": "Hills S.L."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Fischer", "ce:indexed-name": "Fischer M."}], "et-al": null}, "ref-sourcetitle": "Bull World Health Organ"}}, {"ref-fulltext": "Tsai TF, Chang G-J, Yu YX. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed, Philadelphia, PA: Saunders, 1999: 672-710.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "refd-itemidlist": {"itemid": {"$": "0002821687", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "672", "@last": "710"}}, "ref-text": "Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed, Philadelphia, PA: Saunders", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Tsai", "ce:indexed-name": "Tsai T.F."}, {"@seq": "2", "ce:initials": "G.-J.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang G.-J."}, {"@seq": "3", "ce:initials": "Y.X.", "@_fa": "true", "ce:surname": "Yu", "ce:indexed-name": "Yu Y.X."}]}, "ref-sourcetitle": "Japanese Encephalitis Vaccines"}}, {"ref-fulltext": "Centers for Disease Control and Prevention. Health information for international travel 2008. Atlanta, GA: US Department of Health and Human Services, Public Health Service, 2007.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Atlanta, GA: US"}, "refd-itemidlist": {"itemid": {"$": "85082238466", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2007"}}, "ref-text": "Centers for Disease Control and Prevention Department of Health and Human Services, Public Health Service", "ref-sourcetitle": "Health Information for International Travel"}}, {"ref-fulltext": "Tauber E, Dewasthaly S. Japanese encephalitis vaccines-needs, flaws and achievements. Biol Chem 2008; 389:547-50.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Japanese encephalitis vaccines-needs, flaws and achievements"}, "refd-itemidlist": {"itemid": {"$": "45749141637", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "389"}, "pagerange": {"@first": "547", "@last": "550"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Tauber", "ce:indexed-name": "Tauber E."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Dewasthaly", "ce:indexed-name": "Dewasthaly S."}]}, "ref-sourcetitle": "Biol Chem"}}, {"ref-fulltext": "Tsarev SA, Sanders ML, Vaughn DW, Innis BL. Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine 2000; 18(suppl 2): 36-43.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus"}, "refd-itemidlist": {"itemid": {"$": "0034724247", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "36", "@last": "43"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.A.", "@_fa": "true", "ce:surname": "Tsarev", "ce:indexed-name": "Tsarev S.A."}, {"@seq": "2", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Sanders", "ce:indexed-name": "Sanders M.L."}, {"@seq": "3", "ce:initials": "D.W.", "@_fa": "true", "ce:surname": "Vaughn", "ce:indexed-name": "Vaughn D.W."}, {"@seq": "4", "ce:initials": "B.L.", "@_fa": "true", "ce:surname": "Innis", "ce:indexed-name": "Innis B.L."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Halstead SB, Jacobson J. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 5th ed. Philadelphia: WB Saunders and Company, 2008:311-352.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Japanese encephalitis vaccines. in"}, "refd-itemidlist": {"itemid": {"$": "57849164452", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "311", "@last": "352"}}, "ref-text": "Plotkin SA, Orenstein WA, eds. Vaccines. 5th ed. Philadelphia: WB Saunders", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.B.", "@_fa": "true", "ce:surname": "Halstead", "ce:indexed-name": "Halstead S.B."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Jacobson", "ce:indexed-name": "Jacobson J."}]}, "ref-sourcetitle": "And Company"}}, {"ref-fulltext": "Pan XL, Liu H, Wang HY, et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol 2011; 85:9847-53.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Emergence of genotype i of Japanese encephalitis virus as the dominant genotype in Asia"}, "refd-itemidlist": {"itemid": {"$": "80053981794", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "85"}, "pagerange": {"@first": "9847", "@last": "9853"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "X.L.", "@_fa": "true", "ce:surname": "Pan", "ce:indexed-name": "Pan X.L."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu H."}, {"@seq": "3", "ce:initials": "H.Y.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang H.Y."}], "et-al": null}, "ref-sourcetitle": "J Virol"}}, {"ref-fulltext": "Li MH, Fu SH, Chen WX, et al. Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis 2011; 5:e1231.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Genotype v Japanese encephalitis virus is emerging"}, "refd-itemidlist": {"itemid": {"$": "79960942589", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "e1231"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li M.H."}, {"@seq": "2", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Fu", "ce:indexed-name": "Fu S.H."}, {"@seq": "3", "ce:initials": "W.X.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen W.X."}], "et-al": null}, "ref-sourcetitle": "PLoS Negl Trop Dis"}}, {"ref-fulltext": "Takhampunya R, Kim HC, Tippayachai B, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J 2011; 8:449.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Emergence of Japanese encephalitis virus genotype v in the Republic of Korea"}, "refd-itemidlist": {"itemid": {"$": "80053173339", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "449"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Takhampunya", "ce:indexed-name": "Takhampunya R."}, {"@seq": "2", "ce:initials": "H.C.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim H.C."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Tippayachai", "ce:indexed-name": "Tippayachai B."}], "et-al": null}, "ref-sourcetitle": "Virol J"}}, {"ref-fulltext": "Nga PT, del Carmen Parquet M, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 2004; 85(Pt 6):1625-31.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: Implications for frequent introductions of JEV from Southeast Asia to East Asia"}, "refd-itemidlist": {"itemid": {"$": "2942661866", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "85"}, "pagerange": {"@first": "1625", "@last": "1631"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.T.", "@_fa": "true", "ce:surname": "Nga", "ce:indexed-name": "Nga P.T."}, {"@seq": "2", "ce:initials": "P.M.", "@_fa": "true", "ce:surname": "Del Carmen", "ce:indexed-name": "Del Carmen P.M."}, {"@seq": "3", "ce:initials": "V.D.", "@_fa": "true", "ce:surname": "Cuong", "ce:indexed-name": "Cuong V.D."}], "et-al": null}, "ref-sourcetitle": "J Gen Virol"}}, {"ref-fulltext": "Nitatpattana N, Dubot-Peres A, Gouilh MA, et al. Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis 2008; 14:1762-5.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Change in Japanese encephalitis virus distribution"}, "refd-itemidlist": {"itemid": {"$": "55549146124", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "1762", "@last": "1765"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Nitatpattana", "ce:indexed-name": "Nitatpattana N."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Dubot-Peres", "ce:indexed-name": "Dubot-Peres A."}, {"@seq": "3", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Gouilh", "ce:indexed-name": "Gouilh M.A."}], "et-al": null}, "ref-sourcetitle": "Thailand. Emerg Infect Dis"}}, {"ref-fulltext": "Erra EO, Askling HH, Yoksan S, et al. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis 2013; 56:267-70.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes"}, "refd-itemidlist": {"itemid": {"$": "84871798025", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "267", "@last": "270"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.O.", "@_fa": "true", "ce:surname": "Erra", "ce:indexed-name": "Erra E.O."}, {"@seq": "2", "ce:initials": "H.H.", "@_fa": "true", "ce:surname": "Askling", "ce:indexed-name": "Askling H.H."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Yoksan", "ce:indexed-name": "Yoksan S."}], "et-al": null}, "ref-sourcetitle": "Clin Infect Dis"}}, {"ref-fulltext": "Fan YC, Chen JM, Chiu HC, et al. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl Trop Dis 2012; 6:e1834.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Partially neutralizing potency against emerging genotype i virus among children received formalin-inactivated Japanese encephalitis virus vaccine"}, "refd-itemidlist": {"itemid": {"$": "84866944272", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "e1834"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.C.", "@_fa": "true", "ce:surname": "Fan", "ce:indexed-name": "Fan Y.C."}, {"@seq": "2", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen J.M."}, {"@seq": "3", "ce:initials": "H.C.", "@_fa": "true", "ce:surname": "Chiu", "ce:indexed-name": "Chiu H.C."}], "et-al": null}, "ref-sourcetitle": "PLoS Negl Trop Dis"}}, {"ref-fulltext": "Jia L, Wang Z, Yu Y. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-Type JE viruses. Chin Med J (Engl) 2003; 116:941-3.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-Type JE viruses"}, "refd-itemidlist": {"itemid": {"$": "0037898143", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "116"}, "pagerange": {"@first": "941", "@last": "943"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Jia", "ce:indexed-name": "Jia L."}, {"@seq": "2", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang Z."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yu", "ce:indexed-name": "Yu Y."}]}, "ref-sourcetitle": "Chin Med J (Engl"}}, {"ref-fulltext": "Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, et al. Safety and immunogenicity of a single administration of live-Attenuated Japanese encephalitis vaccine in previously primed 2-To 5-year-olds and naive 12-To 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J 2010; 29:1111-7.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Safety and immunogenicity of a single administration of live-Attenuated Japanese encephalitis vaccine in previously primed 2-To 5-year-olds and naive 12-To 24-month-olds: Multicenter randomized controlled trial"}, "refd-itemidlist": {"itemid": {"$": "78650416836", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "1111", "@last": "1117"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Sirivichayakul", "ce:indexed-name": "Sirivichayakul C."}, {"@seq": "3", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Thisyakorn", "ce:indexed-name": "Thisyakorn U."}], "et-al": null}, "ref-sourcetitle": "Pediatr Infect Dis J"}}, {"ref-fulltext": "Bonaparte M, Dweik B, Feroldi E, et al. Immune response to live-Attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India. BMC Infect Dis 2014; 14:156.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Immune response to live-Attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India"}, "refd-itemidlist": {"itemid": {"$": "84899091780", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "156"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bonaparte", "ce:indexed-name": "Bonaparte M."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Dweik", "ce:indexed-name": "Dweik B."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}], "et-al": null}, "ref-sourcetitle": "BMC Infect Dis"}}, {"ref-fulltext": "Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003; 188:1213-30.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen"}, "refd-itemidlist": {"itemid": {"$": "0141537467", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "188"}, "pagerange": {"@first": "1213", "@last": "1230"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.P.", "@_fa": "true", "ce:surname": "Monath", "ce:indexed-name": "Monath T.P."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Guirakhoo", "ce:indexed-name": "Guirakhoo F."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Nichols", "ce:indexed-name": "Nichols R."}], "et-al": null}, "ref-sourcetitle": "J Infect Dis"}}, {"ref-fulltext": "Monath TP, McCarthy K, Bedford P, et al. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 2002; 20:1004-18.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Clinical proof of principle for ChimeriVax: Recombinant live, attenuated vaccines against flavivirus infections"}, "refd-itemidlist": {"itemid": {"$": "18544410924", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "1004", "@last": "1018"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.P.", "@_fa": "true", "ce:surname": "Monath", "ce:indexed-name": "Monath T.P."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "McCarthy", "ce:indexed-name": "McCarthy K."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Bedford", "ce:indexed-name": "Bedford P."}], "et-al": null}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Chambers TJ, Nestorowicz A, Mason PW, Rice CM. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 1999; 73:3095-101.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Yellow fever/Japanese encephalitis chimeric viruses: Construction and biological properties"}, "refd-itemidlist": {"itemid": {"$": "0033046765", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "73"}, "pagerange": {"@first": "3095", "@last": "3101"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.J.", "@_fa": "true", "ce:surname": "Chambers", "ce:indexed-name": "Chambers T.J."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Nestorowicz", "ce:indexed-name": "Nestorowicz A."}, {"@seq": "3", "ce:initials": "P.W.", "@_fa": "true", "ce:surname": "Mason", "ce:indexed-name": "Mason P.W."}, {"@seq": "4", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Rice", "ce:indexed-name": "Rice C.M."}]}, "ref-sourcetitle": "J Virol"}}, {"ref-fulltext": "Hombach J, Solomon T, Kurane I, Jacobson J, Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 2005; 23:5205-11.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva"}, "refd-itemidlist": {"itemid": {"$": "26644464588", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2005", "@issue": "23"}, "pagerange": {"@first": "5205", "@last": "5211"}}, "ref-text": "2-3 September", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hombach", "ce:indexed-name": "Hombach J."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Solomon", "ce:indexed-name": "Solomon T."}, {"@seq": "3", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Kurane", "ce:indexed-name": "Kurane I."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Jacobson", "ce:indexed-name": "Jacobson J."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Wood", "ce:indexed-name": "Wood D."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "World Health Organization. Japanese encephalitis vaccines. Wkly Epidemiol Rec 2015; 90:69-88.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Japanese encephalitis vaccines"}, "refd-itemidlist": {"itemid": {"$": "84929512719", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "90"}, "pagerange": {"@first": "69", "@last": "88"}}, "ref-text": "World Health Organization", "ref-sourcetitle": "Wkly Epidemiol Rec"}}, {"ref-fulltext": "Feroldi E, Pancharoen C, Kosalaraksa P, et al. Single-dose, live-Attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother 2012; 8:929-37.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Single-dose, live-Attenuated Japanese encephalitis vaccine in children aged 12-18 months: Randomized, controlled phase 3 immunogenicity and safety trial"}, "refd-itemidlist": {"itemid": {"$": "84864068467", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "929", "@last": "937"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pancharoen", "ce:indexed-name": "Pancharoen C."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Kosalaraksa", "ce:indexed-name": "Kosalaraksa P."}], "et-al": null}, "ref-sourcetitle": "Hum Vaccin Immunother"}}, {"ref-fulltext": "Feroldi E, Capeding MR, Boaz M, Gailhardou S, Meric C, Bouckenooghe A. Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Hum Vaccin Immunother 2013; 9:889-97.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children"}, "refd-itemidlist": {"itemid": {"$": "84877144130", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "889", "@last": "897"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, {"@seq": "2", "ce:initials": "M.R.", "@_fa": "true", "ce:surname": "Capeding", "ce:indexed-name": "Capeding M.R."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Boaz", "ce:indexed-name": "Boaz M."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gailhardou", "ce:indexed-name": "Gailhardou S."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Meric", "ce:indexed-name": "Meric C."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bouckenooghe", "ce:indexed-name": "Bouckenooghe A."}]}, "ref-sourcetitle": "Hum Vaccin Immunother"}}, {"ref-fulltext": "Chokephaibulkit K, Sabchareon A, Thisyakorn U, et al. Long-Term neutralizing antibody response to a booster dose of a novel live attenuated Japanese encephalitis vaccine (JE-CV-IMOJEV\u00ae) in a pediatric population. Presented at: Seventh Asian Congress of Pediatric Infectious Disease; 12-15 October 2014; Beijing, China.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Long-Term neutralizing antibody response to a booster dose of a novel live attenuated Japanese encephalitis vaccine (JE-CV-IMOJEV\u00ae) in a pediatric population"}, "refd-itemidlist": {"itemid": {"$": "85053765586", "@idtype": "SGR"}}, "ref-text": "Presented At 12-15 October Beijing, China", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sabchareon", "ce:indexed-name": "Sabchareon A."}, {"@seq": "3", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Thisyakorn", "ce:indexed-name": "Thisyakorn U."}], "et-al": null}, "ref-sourcetitle": "Seventh Asian Congress of Pediatric Infectious Disease"}}, {"ref-fulltext": "Feroldi E, Bailleux F, Monfredo C, Bouckenooghe A. Modeling the long-Term persistence of neutralizing antibodies after booster vaccination with a novel live attenuated Japanese encephalitis vaccine (JE-CV)-modeling Ab persistence in children. Presented at: Eighth World Congress of theWorld Society for Pediatric Infectious Diseases; 19-22 November 2013; Cape Town, South Africa.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Modeling the long-Term persistence of neutralizing antibodies after booster vaccination with a novel live attenuated Japanese encephalitis vaccine (JE-CV)-modeling Ab persistence in children"}, "refd-itemidlist": {"itemid": {"$": "85019286605", "@idtype": "SGR"}}, "ref-text": "Presented At 19-22 November Cape Town, South Africa", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Bailleux", "ce:indexed-name": "Bailleux F."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Monfredo", "ce:indexed-name": "Monfredo C."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bouckenooghe", "ce:indexed-name": "Bouckenooghe A."}]}, "ref-sourcetitle": "Eighth World Congress of TheWorld Society for Pediatric Infectious Diseases"}}, {"ref-fulltext": "Hombach J, Barrett AD, Cardosa MJ, et al. Review on flavivirus vaccine development: proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand. Vaccine 2005; 23:2689-95.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the world health organization and the Thai ministry of public health"}, "refd-itemidlist": {"itemid": {"$": "15044359108", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2005", "@issue": "23"}, "pagerange": {"@first": "2689", "@last": "2695"}}, "ref-text": "Bangkok, Thailand World Health Organization and the Thai Ministry of Public Health, 26-27 April", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hombach", "ce:indexed-name": "Hombach J."}, {"@seq": "2", "ce:initials": "A.D.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett A.D."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Cardosa", "ce:indexed-name": "Cardosa M.J."}], "et-al": null}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Beasley DW, Li L, Suderman MT, et al. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 2004; 22:3722-6.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine"}, "refd-itemidlist": {"itemid": {"$": "4143125552", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "3722", "@last": "3726"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.W.", "@_fa": "true", "ce:surname": "Beasley", "ce:indexed-name": "Beasley D.W."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li L."}, {"@seq": "3", "ce:initials": "M.T.", "@_fa": "true", "ce:surname": "Suderman", "ce:indexed-name": "Suderman M.T."}], "et-al": null}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Wills MR, Sil BK, Cao JX, Yu YX, Barrett AD. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: A comparison with isolates of the virus covering a wide geographic area. Vaccine 1992; 10:861-72.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: A comparison with isolates of the virus covering a wide geographic area"}, "refd-itemidlist": {"itemid": {"$": "0026693564", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "861", "@last": "872"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.R.", "@_fa": "true", "ce:surname": "Wills", "ce:indexed-name": "Wills M.R."}, {"@seq": "2", "ce:initials": "B.K.", "@_fa": "true", "ce:surname": "Sil", "ce:indexed-name": "Sil B.K."}, {"@seq": "3", "ce:initials": "J.X.", "@_fa": "true", "ce:surname": "Cao", "ce:indexed-name": "Cao J.X."}, {"@seq": "4", "ce:initials": "Y.X.", "@_fa": "true", "ce:surname": "Yu", "ce:indexed-name": "Yu Y.X."}, {"@seq": "5", "ce:initials": "A.D.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett A.D."}]}, "ref-sourcetitle": "Vaccine"}}, {"ref-fulltext": "Paranjpe S, Banerjee K. Phylogenetic analysis of the envelope gene of Japanese encephalitis virus. Virus Res 1996; 42:107-17.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Phylogenetic analysis of the envelope gene of Japanese encephalitis virus"}, "refd-itemidlist": {"itemid": {"$": "0030005490", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "42"}, "pagerange": {"@first": "107", "@last": "117"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Paranjpe", "ce:indexed-name": "Paranjpe S."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Banerjee", "ce:indexed-name": "Banerjee K."}]}, "ref-sourcetitle": "Virus Res"}}]}}}}, "affiliation": [{"affiliation-city": "Lyon", "@id": "60065719", "affilname": "Sanofi Pasteur SA", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60065719", "affiliation-country": "France"}, {"affiliation-city": "Bangkok", "@id": "60199575", "affilname": "Siriraj Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575", "affiliation-country": "Thailand"}, {"affiliation-city": "New York", "@id": "60090013", "affilname": "International AIDS Vaccine Initiative", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090013", "affiliation-country": "United States"}, {"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}, {"affiliation-city": "Nakhon Pathom", "@id": "60012718", "affilname": "Mahidol University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718", "affiliation-country": "Thailand"}, {"affiliation-city": "Singapore City", "@id": "118763766", "affilname": "Clinical R andD and Medical Affairs", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118763766", "affiliation-country": "Singapore"}], "coredata": {"srctype": "j", "eid": "2-s2.0-85021858117", "dc:description": "Background. The live-Attenuated Japanese encephalitis (JE) vaccine (JE-CV; IMOJEV) induces a protective response in children. A shift in circulating JE virus strains suggests that a genotype shift phenomenon may occur throughout Southeast Asia. We assessed the neutralization of wild-Type (WT) JE virus isolates at distal time points after vaccination. Methods. We analyzed serum samples from a subset of 47 children who had received a JE-CV booster after an inactivated JE vaccine primary immunization. We measured antibody titers (50% plaque reduction neutralization test) using a panel of WT JE strains at baseline, then after the booster at 28 days and 6 months in all subjects present at the time points and in a subset at year 5. Three additional recent isolates were tested at year 5. Results. Of 47 subjects, 43 (91.5%) subjects had JE neutralizing antibody titers =10 (reciprocal serum dilution) against the homologous strain before JE-CV boost; all were seroprotected up to year 5 after the JE-CV boost. Baseline WT seroprotection ranged between 78.7% and 87.2%; all subjects were seroprotected against the 4 WT strains at 28 days and 6 months; year 5 seroprotection ranged between 95.7% and 97.9%. Similar rates of protection against 3 additional WT isolates were observed at year 5. Conclusions. The long-Term immune responses induced after a JE-CV booster dose in toddlers were able to neutralize WT viruses from various genotypes circulating in Southeast Asia and India. Clinical Trials Registration. NCT00621764.", "pubmed-id": "27815383", "prism:coverDate": "2017-01-15", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85021858117", "dc:creator": {"author": [{"ce:given-name": "Emmanuel", "preferred-name": {"ce:given-name": "Emmanuel", "ce:initials": "E.", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, "@seq": "1", "ce:initials": "E.", "@_fa": "true", "affiliation": [{"@id": "60065719", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60065719"}, {"@id": "60090013", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090013"}], "ce:surname": "Feroldi", "@auid": "23388879400", "author-url": "https://api.elsevier.com/content/author/author_id/23388879400", "ce:indexed-name": "Feroldi E."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85021858117"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021858117&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85021858117&origin=inward"}], "source-id": "22440", "citedby-count": "16", "prism:volume": "215", "subtype": "ar", "dc:title": "Persistence of wild-type Japanese encephalitis virus strains cross-neutralization 5 years after JE-CV immunization", "openaccess": "1", "prism:issn": "15376613 00221899", "publishercopyright": "\u00a9 The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.", "prism:issueIdentifier": "2", "subtypeDescription": "Article", "prism:publicationName": "Journal of Infectious Diseases", "prism:pageRange": "221-227", "prism:endingPage": "227", "openaccessFlag": "true", "prism:doi": "10.1093/infdis/jiw533", "prism:startingPage": "221", "dc:identifier": "SCOPUS_ID:85021858117", "dc:publisher": "Oxford University Press"}, "idxterms": {"mainterm": [{"$": "Animals", "@weight": "b", "@candidate": "n"}, {"$": "Antibodies, Neutralizing", "@weight": "b", "@candidate": "n"}, {"$": "Antibodies, Viral", "@weight": "b", "@candidate": "n"}, {"$": "Asia, Southeastern", "@weight": "b", "@candidate": "n"}, {"$": "Child, Preschool", "@weight": "b", "@candidate": "n"}, {"$": "Cross Reactions", "@weight": "a", "@candidate": "n"}, {"$": "Encephalitis Virus, Japanese", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "India", "@weight": "b", "@candidate": "n"}, {"$": "Japanese Encephalitis Vaccines", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Time Factors", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Genotypes"}, {"@_fa": "true", "$": "Japanese encephalitis vaccines"}, {"@_fa": "true", "$": "Long-Term protection"}, {"@_fa": "true", "$": "Wild-Type strains; cross-neutralization"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Medicine (all)", "@code": "2700", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Emmanuel", "preferred-name": {"ce:given-name": "Emmanuel", "ce:initials": "E.", "ce:surname": "Feroldi", "ce:indexed-name": "Feroldi E."}, "@seq": "1", "ce:initials": "E.", "@_fa": "true", "affiliation": [{"@id": "60065719", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60065719"}, {"@id": "60090013", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090013"}], "ce:surname": "Feroldi", "@auid": "23388879400", "author-url": "https://api.elsevier.com/content/author/author_id/23388879400", "ce:indexed-name": "Feroldi E."}, {"ce:given-name": "Mark", "preferred-name": {"ce:given-name": "Mark", "ce:initials": "M.", "ce:surname": "Boaz", "ce:indexed-name": "Boaz M."}, "@seq": "2", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60065719", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60065719"}, "ce:surname": "Boaz", "@auid": "57209785027", "author-url": "https://api.elsevier.com/content/author/author_id/57209785027", "ce:indexed-name": "Boaz M."}, {"ce:given-name": "Sutee", "preferred-name": {"ce:given-name": "Sutee", "ce:initials": "S.", "ce:surname": "Yoksan", "ce:indexed-name": "Yoksan S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Yoksan", "@auid": "7003989454", "author-url": "https://api.elsevier.com/content/author/author_id/7003989454", "ce:indexed-name": "Yoksan S."}, {"ce:given-name": "Kulkanya", "preferred-name": {"ce:given-name": "Kulkanya", "ce:initials": "K.", "ce:surname": "Chokephaibulkit", "ce:indexed-name": "Chokephaibulkit K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60199575", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"}, "ce:surname": "Chokephaibulkit", "@auid": "7003974471", "author-url": "https://api.elsevier.com/content/author/author_id/7003974471", "ce:indexed-name": "Chokephaibulkit K."}, {"ce:given-name": "Usa", "preferred-name": {"ce:given-name": "Usa", "ce:initials": "U.", "ce:surname": "Thisyakorn", "ce:indexed-name": "Thisyakorn U."}, "@seq": "5", "ce:initials": "U.", "@_fa": "true", "affiliation": {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}, "ce:surname": "Thisyakorn", "@auid": "7005343826", "author-url": "https://api.elsevier.com/content/author/author_id/7005343826", "ce:indexed-name": "Thisyakorn U."}, {"ce:given-name": "Chitsanu", "preferred-name": {"ce:given-name": "Chitsanu", "ce:initials": "C.", "ce:surname": "Pancharoen", "ce:indexed-name": "Pancharoen C."}, "@seq": "6", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}, "ce:surname": "Pancharoen", "@auid": "7006397913", "author-url": "https://api.elsevier.com/content/author/author_id/7006397913", "ce:indexed-name": "Pancharoen C."}, {"ce:given-name": "C\u00e9line", "preferred-name": {"ce:given-name": "C\u00e9line", "ce:initials": "C.", "ce:surname": "Monfredo", "ce:indexed-name": "Monfredo C."}, "@seq": "7", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60065719", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60065719"}, "ce:surname": "Monfredo", "@auid": "57191196788", "author-url": "https://api.elsevier.com/content/author/author_id/57191196788", "ce:indexed-name": "Monfredo C."}, {"ce:given-name": "Alain", "preferred-name": {"ce:given-name": "Alain", "ce:initials": "A.", "ce:surname": "Bouckenooghe", "ce:indexed-name": "Bouckenooghe A."}, "@seq": "8", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "118763766", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118763766"}, "ce:surname": "Bouckenooghe", "@auid": "18233281300", "author-url": "https://api.elsevier.com/content/author/author_id/18233281300", "ce:indexed-name": "Bouckenooghe A."}]}}}